Assessment of the operational characteristics of the National Comprehensive Cancer Network distress management tool, v. 2.2018, in patients seen at the Instituto Nacional de Cancerología, Bogotá
Abstract
Introduction: Cancer patients have significant levels of emotional distress. The National Comprehensive Cancer Network (NCCN) developed the distress management tool to quickly assess significant distress in oncological patients who require intervention. For its use in Colombia, we made its cross-cultural adaptation and validation.
Objective: To determine the operative characteristics of the distress management tool, version 2.2018, in patients seen at the Instituto Nacional de Cancerología (INC) in Colombia.
Materials and methods: Counting with the authorization from the NCCN, we translated, made the cross-cultural adaptation, and evaluated the operational characteristics of the tool. We included 343 cancer patients seen at the INC, who filled out the cross-culturally adapted instrument. A diagnostic test study was carried out with a semi-structured interview as a reference.
Results: The patients had an average age of 49.7 years (SD=15) and the majority were women (67%). The instrument had an area under the ROC curve of 0.81 (95% CI: 0.77 -0.86); its optimal cut-off point was 3.5 approached to 4 when using integers on the scale; its sensitivity was 0.81 (95% CI: 0.76 - 0.85), and its specificity, 0.69 (95% CI: 0.64 - 0.74). The agreement percentage between the result of the interview and the instrument was 73% (kappa = 0.64; p< 0.001).
Conclusions: The distress management tool allowed for the detection of moderate to severe distress requiring intervention and management. This instrument was adapted and validated in cancer patients in Colombia keeping the cutoff point at ≥ 4 as in the original version.
Downloads
References
Moreno A, Acosta M, Krikorian A, Palacio C. Malestar emocional, ansiedad y depresión en pacientes oncológicos colombianos y su relación con la competencia percibida. Av Psicol Latinoam 2015;33:517-29. https://doi.org/10.12804/revistas.urosario.edu.co/apl/a.3148
Almanza J, Rosario I, Silva J, Huerta R. Distrés psicosocial y trastornos mentales en una muestra de pacientes mexicanos con cáncer. Rev Sanid Milit Mex. 2009;63:148-55.
Hernández M, Cruzado JA, Prado C, Rodríguez E. Salud mental y malestar emocional en pacientes con cáncer. Psicooncología. 2012;9:233-57. https://doi.org/10.5209/rev_PSIC.2013.v9.n2-3.40895
Holland JC, Deshields TL, Andersen B, Braun I, Breitbart WS, Brewer BW, et al. Distress management. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Version 2. Philadelphia: The National Comprehensive Cancer Network; 2018. p.1-92.
Singer S, Szalai C, Briest S, Brown A, Dietz A, Einenkel J, et al. Co-morbid mental health conditions in cancer patients at working age - Prevalence, risk profiles, and care uptake. Psycho-oncology. 2013;22:2291-7. https://doi.org/10.1002/pon.3282
Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751-7. https://doi.org/10.1001/jama.1983.03330300035030
Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10:19-28. https://doi.org/10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-6
Kendall J, Glaze K, Oakland S, Hansen J, Parry C. What do 1281 distress screeners tell us about cancer patients in a community cancer center? Psycho-Oncology. 2011;20:594-600. https://doi.org/10.1002/pon.1907
Au H, Ringash J, Brundage M, Palmer M, Richardson H, Meyer RM, et al. Added value of health-related quality of life measurement in cancer clinical trials: The experience of the NCIC CTG. Expert Rev Pharmacoecon Outcomes Res. 2010;10:119-28. https://doi.org/10.1586/erp.10.15
Fawzy FI. Psychosocial interventions for patients with cancer: What works and what doesn’t. Eur J Cancer. 1999;35:1559-64. https://doi.org/10.1016/S0959-8049(99)00191-4
Fann J, Ell K, Sharpe M. Integrating Psychosocial Care Into Cancer Services. J Clin Oncol. 2012;30:1178-86. https://doi.org/10.1200/JCO.2011.39.7398
Ryan H, Schofield P, Cockburn J, Butow P, Tattersall M, Turner J, et al. How to recognize and manage psychological distress in cancer patients. Eur J Cancer Care. 2005;14:7-15. https://doi.org/10.1111/j.1365-2354.2005.00482.x
Adler N, Page A, Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting. Cancer care for the whole patient: Meeting Psychosocial Health Needs. Washington: National Academies Press; 2008. p. 23-83.
Canadian Association of Psychosocial Oncology. The emotional facts of life with cancer. Fourth edition. Cánada: Enbridge; 2012. p. 4-22.
Commission on Cancer. Cancer Program Standards 2012: Ensuring Patient-Centered Care. V1.2.1. Chicago: American College of Surgeons; 2012. p. 25-48.
Aliaga J, Rodríguez L, Ponce C, Frisancho A, Enríquez J. Escala de desesperanza de Beck (BHS): adaptación y características psicométricas. Rev Investig Psicol 2006;9:69-79. https://doi.org/10.15381/rinvp.v9i1.4029
Ramos JC, Cordero A. A new validation of the Hamilton Rating Scale for Depression. J Psychiatr Res. 1988;22:21-8. https://doi.org/10.1016/0022-3956(88)90024-6
Rico J, Restrepo M, Molina M. Adaptación y validación de la escala hospitalaria de ansiedad y depresión (HAD) en una muestra de pacientes con cáncer del Instituto Nacional de Cancerologia de Colombia. Av Medición. 2005;3:73-86.
Londoño C, Alejo IE. Instrumentos usados en Colombia para evaluar la dimensión psicológica del proceso salud-enfermedad. Bogotá: Logos Vestigium; 2017. p. 39-67. http://hdl.handle.net/10983/15964
Hernández M, Cruzado J, Prado C, Rodríguez E, Hernández C, González M, et al. Salud mental y malestar emocional en pacientes con cáncer. Psicooncología. 2012;9:233-57. https://doi.org/10.5209/rev_PSIC.2013.v9.n2-3.40895
Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: A systematic review of assessment instruments. J Natl Cancer Inst. 2009;101:1464-88. https://doi.org/10.1093/jnci/djp336
Roth A, Kornblith A, Batel L, Peabody E, Scher H, Holland J. Rapid screening for psychologic distress in men with prostate carcinoma. Am Cancer Soc. 1998;82:1904-8. https://doi.org/10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X
Cutillo A, O’Hea E, Person S, Lessard D, Harralson T, Boudreaux E. The Distress Thermometer: Cut off points and clinical utility. Oncol Nurs Forum. 2017;44:329-36. https://doi.org/10.1188/17.ONF.329-336
Donovan K, Grassi L, McGinty H, Jacobsen P. Validation of the Distress Thermometer worldwide: State of the science. Psycho-oncology. 2014;23:241-50. https://doi.org/10.1002/pon.3430
Holland J, Andersen B, Breitbart W, Buchmann L, Compas B, Deshields T, et al. Distress management. J Nat Compr Canc Netw. 2013;11:190-209. https://doi.org/10.6004/jnccn.2013.0027
Muñoz S, Sánchez R, Del Toro L. Adaptación transcultural al español de la escala Distress Management del NCCN versión 2.2018 para su utilización en pacientes oncológicos en Colombia. Rev Colomb Cancerol. 2019;23:144-51. https://doi.org/10.35509/01239015.12
Perkins N, Schisterman E. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670-5. https://doi.org/10.1093/aje/kwj063
Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74. https://doi.org/10.2307/2529310
Iskandarsyah A, Klerk C, Suardi D, Soemitro M, Sadarjoen SS. The Distress Thermometer and its validity: A first psychometric study in Indonesian women with breast cancer. 2013;8:1-7. https://doi.org/10.1371/journal.pone.0056353
Almanza J, Rosario I, Pérez S. Traducción, adaptación y validación del termómetro de distrés en una muestra de pacientes mexicanos con cáncer. Rev Sanid Milit Mex. 2008;62:209-17.
Priede A, Torres M, Hoyuela F, Herrán A, González C. El termómetro del distrés como prueba de cribado de ansiedad y depresión en pacientes oncológicos recién diagnosticados. Psicooncología. 2014;11:31-43. https://doi.org/10.5209/rev_PSIC.2014.v11.n1.44915
Shim E, Shin Y, Jeon H, Hahm B. Distress and its correlates in Korean cancer patients: Pilot use of the distress thermometer and the problem list. Psychooncology. 2008;17:548-55. https://doi.org/10.1002/pon.1275
Meyer T, Klemme H, Herrmann C. Depression but not anxiety is a significant predictor of physicians’ assessments of medical status in physically ill patients. Psychother Psychosom. 2017;69:147-54. https://doi.org/10.1159/000012383
Ozalp E, Cankurtaran E, Soygür H, Geyik P, Jacobsen P. Screening for psychological distress in Turkish cancer patients. Psychooncology. 2007;16:304-11. https://doi.org/10.1002/pon.1059
Some similar items:
- Erika Santamaría, Nubia Ponce, Concepción Puerta, Cristina Ferro, Validation of PCR as a tool for the detection of Leishmania (Vianna) spp. parasites in the Lutzomyia (Diptera: Psychodidae) vector. , Biomedica: Vol. 25 No. 2 (2005)
- Ruth Aralí Martínez, Fredi Alexander Díaz, Luis Angel Villar, Evaluation of the World Health Organization clinical definition of dengue. , Biomedica: Vol. 25 No. 3 (2005)
- Evelyn Mendoza, Carlos Crismatt, Ramón Matos, Olga Sabagh, Mercedes Campo, Johana Cepeda, Daniel Villanueva, Diagnosis of small intestinal bacterial overgrowth in children: the use of lactulose in the breath hydrogen test as a screening test , Biomedica: Vol. 27 No. 3 (2007)
- Xiomara Ríos, Jéssica Inés Vergara, Edwin Antonio Wandurraga, Juan José Rey, Clinical assessment of body hair in Colombian women: determining the cutoff score that defines hirsutism , Biomedica: Vol. 33 No. 3 (2013)
- S. Máttar, F. Gamboa, A. Centella, S. Arrieta, La infección del tracto urinario (ITU) en un hospital universitario de Santafé de Bogotá: etiología y evaluación de los antimicrobianos , Biomedica: Vol. 14 No. 3 (1994)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
